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SI Methods
Generation of Expression Constructs. DNA fragments of Homo
sapiens DPF2 were amplified by PCR and cloned into the vector
pGEX-6P-1 (GE Healthcare) and the lentiviral expression vec-
tor CDH-EF1-MCS-(PGK-GFP) (System Biosciences). DPF2
mutants were generated by QuikChange mutagenesis (Stra-
tagene) and confirmed by DNA sequencing. Viruses were pro-
duced by transfection of 293T cells with vectors, according to
standard protocols (1). Details of all constructs are listed in
Tables S1 and S4.
Recombinant Protein Expression and Purification. All proteins were
expressed in Escherichia coli BL21-CodonPlus(DE3)-RIL cells
(Stratagene) grown in LB media supplemented with 0.1 mM
zinc acetate and appropriate antibiotics. Protein expression
was induced at an OD600 of ∼0.6 with 0.5 mM isopropyl β-D-
thiogalactoside (IPTG) for 18 h at 18 °C. Cells were harvested by
centrifugation and resuspended in a buffer containing 20 mM
Tris (pH 8.0), 100 mM NaCl, 5 mM DTT, 2 μM bovine lung
aprotinin (Sigma), and complete EDTA-free protease inhibitor
mixture (Roche), and subsequently flash-frozen in liquid nitro-
gen. Thawed cells were lysed with a cell disrupter (Avestin) and
the lysate was centrifuged for 1 h at 40,000 × g. The cleared lysate
was applied to a glutathione Sepharose column (GE Healthcare)
equilibrated in buffer containing 20 mM Tris (pH 8.0), 100 mM
NaCl, and 5 mM DTT, and eluted via a glutathione gradient.
Pooled fractions were cleaved with PreScission protease (GE
Healthcare) for 12 h. Cleaved protein was bound to a HiTrapQ
HP (GE Healthcare) column and eluted via a linear NaCl gradi-
ent, concentrated, and injected onto a HiLoad 16/60 Superdex
75 column equilibrated in 20 mM Tris (pH 8.0), 100 mM NaCl,
and 5 mM DTT. Pooled fractions were concentrated to 15 mg/mL
and used in subsequent crystallization trials or for in vitro binding
assays.
Structure Determination and Refinement. Crystals of DPF2PHD
were grown at 21 °C in hanging drops containing 1 μL of the
protein and 1 μL of a reservoir solution consisting of 2.2 M
ammonium sulfate and 0.15 M ammonium citrate. Crystals grew
in the tetragonal space group I422 and reached a maximum size
of ∼500 μm × 500 μm × 500 μm within a week. For cryo-
protection, crystals were stabilized in the crystallization solu-
tion supplemented with 20% (vol/vol) ethylene glycol (added in
5% increments). X-ray diffraction data were collected at 100 K
at beamline 12–2 at the Stanford Synchrotron Radiation Light-
source (SSRL). X-ray intensities were processed using XDS (2).
The structure was solved by single-wavelength anomalous dis-
persion using X-ray diffraction data collected using the anoma-
lous scattering of the endogenous Zn2+ ions. Identification of
heavy metal sites, calculation of phases, and density modification
were performed in PHENIX (3). Iterative rounds of model
building and refinement in Coot and PHENIX yielded final
models containing all residues of DPF2PHD fragment, except for
residues 387–391, for which no electron density was observed (3,
4). The final Rwork and Rfree values were 14.6% and 18.7%, re-
spectively. The model possesses excellent stereochemical pa-
rameters with no residues in the disallowed regions of the
Ramachandran plot as assessed with MolProbity (5). For details
of the data collection and refinement statistics, see Table S2.
CD Spectroscopy. Purified DPF2 wild-type and triple mutant
protein (DPF2MUT) was dialyzed into buffer containing 20 mM
sodium phosphate (pH 8.0) and 1 mM DTT and concentrated
to ∼15 mg/mL. CD spectra were measured with a Circular Di-
chroism Spectrometer Model 430 (Aviv Biomedical) in triplicate.
Data were collected at protein concentrations of 0.25 mg/mL at
25 °C in 1-nm increments and an averaging time of 5 s.
ITC Measurements. ITC measurements were performed at 25 °C
using a MicroCal ITC200 Calorimeter (Malvern). Protein sam-
ples were stored in a buffer containing 25 mM HEPES (pH 8.0),
100 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine (TCEP),
and 10% (vol/vol) glycerol. The lyophilized H3 and H4 peptide
variants were dissolved in buffer containing 25 mM HEPES
(pH 8.0), 2 mMTCEP, and 10% (vol/vol) glycerol to generate 100-mM
stock solutions. For measurements at 50 mM NaCl or 100 mM
NaCl concentrations, these peptide stock solutions were diluted
accordingly. All measurements were performed in triplicate. The
heat generated from dilution was subtracted for baseline correction.
Baseline corrected data were analyzed with Origin 7.0 software.
Purification, Infection, and Culture of HSPC CD34+ Cells. CD34+
HSPCs were purified by positive selection using the Midi MACS
(magnetic-activated cell sorting) LS+ separation columns and
isolation kit (Miltenyi) starting with mononuclear cells that were
isolated from CB by Ficoll-Hypaque Plus (GE Healthcare Life
Sciences) density centrifugation. CD34+ cells were cultured
in Iscove’s modified Dulbecco’s medium (Cellgro) 20% BIT
9500 medium (StemCell Technologies) supplemented with SCF
(100 ng/mL), FLT-3 ligand (10 ng/mL), IL-6 (20 ng/mL), and
TPO (100 ng/mL) as the basic culture. CD34+ cells were infected
with high-titer lentiviral concentrated suspensions, with 8 μg/mL
polybrene (Sigma-Aldrich). To differentiate HSPCs, cells were
cultured under the myeloid-promoting conditions: SCF (100 ng/mL),
FLT-3 ligands (10 ng/mL), IL-3 (20 ng/mL), IL-6 (20 ng/mL),
GM-CSF (20 ng/mL), and G-CSF (20 ng/mL) (all purchased
from Peprotech).
Cell Fractionation.Cellular fractions from 293T cells were obtained
using the Subcellular Protein Fractionation Kit for Cultured Cells
(ThermoFisher Scientific). The following antibodies were used to
distinguish the individual fractions: for the cytoplasmic fraction,
Caspase-3 (9665, Cell Signaling); nuclear soluble fraction, Sp-1
(sc-59, Santa Cruz); and chromatin bound fraction, Lamin B
(sc-6216). FLAG-DPF2 was detected using anti-FLAG M2-HRP
(A8592, Sigma Aldrich).
Mass Spectrometry of DPF2 Interacting Proteins. To precipitate
endogenous DPF2, 200 μL of protein A/G magnetic beads
(88803, Thermo Scientific) were cross-linked to 20 μg of the
polyclonal rabbit anti-DPF2 antibody (A303-595A, Bethyl Lab-
oratories) using dimethyl pimelimidate dihydrochloride (D8388,
Sigma-Aldrich). Lysates from SKNO-1 and Kasumi-1 cells were
incubated with 5 μg of anti-DPF2 conjugated beads and eluted
with 50 μL of 1 M glycine (pH 3.0). Proteins were precipitated
using the Proteoextract Protein Precipitation Kit (539180, EMD
Millipore) and submitted for mass spectrometry analysis as a dry
pellet. The following antibodies were used for the confirmation
of SWI/SNF complex interactions with endogenous and FLAG
tagged DPF2: BAF155 (11956, Cell Signaling), SMARCC2
(12760, Cell Signaling), and ACTL6A (ab131272, Abcam).
Immunofluorescence Microscopy. The 293T cells transfected with
pCDNA3.1-FLAG vector harboring wild-type or mutant FLAG-
DPF2 plasmids were grown on coverslips overnight. Cells were
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fixed with 4% (wt/vol) PFA for 10 min in DMEM supplemented
with 10% (vol/vol) FBS and permeabilized for 10 min with PBS
supplemented with 0.25% (vol/vol) Triton-X. Following blocking
in PBST for 1 h, cells were incubated with anti-FLAG antibody
conjugated to FITC (F4049, Sigma-Aldrich) at 1:300 overnight.
Slides were imaged using the Leica SP5 inverted confocal
microscope.
Immunoprecipitation of FLAG-Tagged Constructs. The 293T cells
were transfected with pCDNA3.1-FLAG vector harboring
FLAG-DPF2 wild-type and FLAG-DPF2MUT. Immunoprecipi-
tation for FLAG-DPF2 was conducted overnight by incubating
500 μg of cell lysate with 20 μL of anti-FLAG M2 Magnetic
beads (M8823, Sigma-Aldrich). For histone acetylation assays,
cells were incubated with 1 μM of histone deacetylase inhibitor,
Vorinostat (SAHA, MK0683, Selleckchem), or DMSO for 24 h.
Antibodies used for Western blot were anti-H3 (sc-8654, Santa-
Cruz), anti-H4 (ab17036, Abcam), or anti-FLAG M2 (F1084,
Sigma Aldrich). For the immunoprecipitation of FLAG-RUNX1,
a total of 200,000 HEL cells were infected for 16 h with concen-
trated lentiviral particles (25 multiplicity of infection) and 4 μg/mL
polybrene (Sigma Aldrich). After 24 h, cells were infected for 16 h
with DPF2 or DPF2PHD lentiviral particles at a multiplicity of
infection of 10 and 4 μg/mL polybrene. After 72 h cells were lysed
in nuclei extraction buffer and FLAG-RUNX1 was immunopre-
cipitated with anti-FLAG magnetic beads as indicated above.
DPF2 and DPF2PHD proteins were detected using anti-DPF2 at a
concentration of 1:1,000 (ab74519, Abcam). Virally expressed
DPF2 and DPF2PHD were overexpressed 100-fold in HEL cells
compared with endogenous DPF2.
Generation of Lentivirus. Wild-type, triple mutant, and a region
encompassing the tandem PHD domain of DPF2 were cloned
into the pCDH-EF1-MCS-(PGK-GFP) lentiviral expression
Vector (System Biosciences). Viruses were produced by trans-
fection of 5 million human embryonic kidney 293T cells with 10 μg
of plasmid, using the Calcium Phosphate Transfection Kit
(Invitrogen) with helper plasmids (3.5 μg psPAX2 and 7.5 μg
pMD2.G), according to standard protocols (1). Both helper
plasmids were a gift from Didier Trono (School of Life Sciences,
École Polytechnique Fédérale de Lausanne (EPFL), Lausanne,
Switzerland; Addgene plasmid #12260 and #12259). Details of
all lentiviral constructs are listed in Table S4.
Immunoblot Analysis. Cells were harvested, counted, and washed
with PBS and lysed in cell lysis buffer (Cell Signaling) supple-
mented with protease and phosphatase inhibitors. Lysates were
resolved on 4–12% gradient SDS-PAGE gels and transferred to
0.2-μm nitrocellulose membranes (Bio-Rad). Membranes were
blocked with 5% blotting grade blocker (Bio-Rad) and probed
using DPF2 (S-24) (sc-101943; Santa Cruz) and β-actin (N-21)
(sc-130656; Santa Cruz). For recognition of full-length DPF2
and DPF2PHD, anti-DPF2 antibody was used (ab74519, Abcam).
Flow Cytometry. CD34 cells were isolated from umbilical CB and
transduced with a lentivirus expressing the pCDH-EF1-MCS-
(PGK-GFP) vector alone, wild-type DPF2, or DPF2MUT. Cells
were cultured for 7 d in X-vivo media supplemented with 20%
BIT and myeloid differentiation promoting cytokines (IL-3, IL-6,
SCF, and GM-CSF). Transduced CD34+ cells were stained with
CD11b-PE (BD Pharmingen) and analyzed on a BD FACSCanto
flow cytometer. Infected cells were selected by gating those
expressing GFP and examined for changes in CD11b positivity
using the FloJo analysis software.
RNA-Sequencing and Data Analysis. Human primary CD34+ cells
were purified from umbilical CB using Ficoll separation
followed by magnetic enrichment for CD34+ cells using the
CD34 microbead purification kit (Miltenyl Biotech). Lentivi-
rus particles encoding DPF2 shRNA or a scrambled control
were produced in 293T cells and concentrated using the retro-x
concentrator (Clontech). Cells were infected with lentivirus by
spin infection and harvested 3 d postinfection. Cells positive for
the lentiviral infection were sorted based on GFP positivity using a
fluorescent activated cell sorter. Total RNA was extracted from
the sorted cells using the RNeasy mini kit (Qiagen). RNA-Seq
library prep was carried out using the Illumina TruSeq Total
Stranded kit (RS-122-2201) with Ribo-Zero rRNA reduction
following manufacturer’s standard protocol without modification.
Next, 500 ng of total RNA was used as input with RNA quality
assessed using Agilent Bioanalyzer 2100 Nano 6000. Library
quantification and balancing was done using Kapa Biosciences
Library Quantification (Complete, K4824) run on a Roche LC480
LightCycler. Samples were loaded in a single 300 cycles High
Output NextSEq. 500 V1 flow cell (FC-404-1004) per manufac-
turer’s standard protocol. Experiments were performed in tripli-
cate. Data analysis was performed using the Illumina BaseSpace
platform (https://basespace.illumina.com/home/index) for base-
calling and demultiplexing.
ChIP Assays. Approximately 4 × 106 cells were used per ChIP
reaction after cross-linking with 1% (wt/vol) formaldehyde for
10 min at room temperature. ChIP assays were performed using
ChIP kit from Cell Signaling Technology with an IP grade
DPF2 antibody (Bethyl Laboratories). After reverse cross-link
and purification, the associated DNA was subjected to
qRT-PCR to detect specific DNA sequences in the pre-miR-
223 promoter region. The primers specific to regions 4 and 5 of
the pre-miR-223 promoter region were previously reported in
Vu et al. (6). Quantitative results are represented as percentages
relative to 10% DNA input.
Illustration and Figures. The sequence alignment of DPF2 was
generated using ClustalX2 (7) and colored with Alscript (8).
Figures were generated using PyMOL (www.pymol.org). Electro-
static potential was calculated with Adaptive Poisson-Boltzmann
Solver software (9). The protein interaction network for DPF2 was
generated using Cytoscape.
1. Moffat J, et al. (2006) A lentiviral RNAi library for human and mouse genes applied to
an arrayed viral high-content screen. Cell 124:1283–1298.
2. Kabsch W (2010) XDS. Acta Crystallogr D Biol Crystallogr 66:125–132.
3. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macro-
molecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213–221.
4. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta
Crystallogr D Biol Crystallogr 60:2126–2132.
5. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for
proteins and nucleic acids. Nucleic Acids Res 35:W375–W383.
6. Vu LP, et al. (2013) PRMT4 blocks myeloid differentiation by assembling a methyl-
RUNX1-dependent repressor complex. Cell Reports 5:1625–1638.
7. Jeanmougin F, Thompson JD, Gouy M, Higgins DG, Gibson TJ (1998) Multiple sequence
alignment with Clustal X. Trends Biochem Sci 23:403–405.
8. Barton GJ (1993) ALSCRIPT: A tool to format multiple sequence alignments. Protein
Eng 6:37–40.
9. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nano-
systems: Application to microtubules and the ribosome. Proc Natl Acad Sci USA 98:
10037–10041.
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Fig. S1. Structural analysis of human DPF2PHD. (A) Final 2jFOj–jFCj electron density map countered at 1.0 σ around a stick representation of the Zn2+ co-
ordinating residues of DPF2PHD1 (Left) and DPF2PHD2 (Right). The Zn2+ atoms are shown as orange (PHD1) and gray (PHD2) spheres, respectively. (B) Super-
position of DPF2PHD1 and DPF2PHD2, colored as in Fig. 1. (C) Superposition of the DPF2PHD1 and DPF2PHD2, colored as in Fig. 1, along with representative PHD
domains (PDB ID codes 2KWJ, 2PUY, 3SOU, 4LK9, 4L7X, 4QF3) (1–7), all colored in gray.
1. Zeng L, et al. (2010) Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 466:258–262.
2. Dreveny I, et al. (2014) The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and
modification. Nucleic Acids Res 42:822–835.
3. Gatchalian J, et al. (2013) Dido3 PHD modulates cell differentiation and division. Cell Reports 4:148–158.
4. Li H, et al. (2006) Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442:91–95.
5. Rajakumara E, et al. (2011) PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol Cell 43:275–284.
6. Tallant C, et al. (2015) Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC. Structure 23:80–92.
7. Lan F, et al. (2007) Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 448:718–722.
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Fig. S2. Multispecies sequence alignment of DPF2 homologs. The secondary structure is indicated above the sequence as cylinders (α-helices), arrows
(β-sheets), and lines (coil regions). The numbering below the alignment is relative to human DPF2. Overall sequence conservation at each position is shaded in a
color gradient from white (below 40% identity) to yellow (60% identity) to dark red (100% identity). The secondary structure elements above the tandem PHD
finger domain (residues 270–391) are as observed in the structure presented here and colored in blue, those above the C2H2 zinc finger domain (residues 206–
232) are from the previously solved structure (PDB ID code 3IUF) (1) and colored in orange.
1. Zhang W, et al. (2011) Crystal structure of the Cys2His2-type zinc finger domain of human DPF2. Biochem Biophys Res Commun 413:58–61.
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Fig. S3. Sequence alignment of human d4 family members. (A) The secondary structure is indicated above the sequence as blue cylinders (α-helices), green
arrows (β-sheets), and gray lines (coil regions). The numbering below the alignment is relative to human DPF2. Overall sequence conservation at each position is
shaded in a color gradient from white (below 40% similarity) to yellow (60% similarity) to dark red (100% identity). Purple dots indicate residues mutated in
our biochemical analysis and gray dots indicate residues for which there was no observed electron density. (B) Surface representation of a model of DPF2PHD in
complex with the indicated histone peptides based on the DPF3b solution structures (PDB ID codes 2KWJ and 2KWN) (1). The model is colored according to the
above multispecies sequence alignment.
1. Zeng L, et al. (2010) Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 466:258–262.
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Fig. S4. Biochemical interaction analysis. (A) Sequences and modifications of peptides used in interaction experiments (B) Representative ITC data for in-
teractions between wildtype DPF2 or a triple mutant (DPF2MUT; F275A, R300A, and D346A) and H3 or H4 histone tail peptides at 100 mM NaCl concentration.
Upper parts of each box show raw data and Lower parts show integrated heat changes corrected for heat from dilution. See also Table S3. (C) Representative
ITC data for interactions between RUNX1 peptides and DPF2 at 0 mM NaCl concentration. Upper parts of each box show raw data and Lower parts show
integrated heat changes corrected for heat from dilution. See also Table 1.
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Fig. S5. CD spectroscopy. (A) CD spectra of DPF2 wild-type (DPF2WT, blue) and a triple mutant (DPF2MUT; F275A, R300A, and D346A, red). Spectra were
measured in triplicate at a protein concentration of 0.25 mg/mL at 25 °C. (B) Size-exclusion chromatography analysis of DPF2 wild-type (DPF2WT, blue) and a
triple mutant (DPF2MUT; F275A, R300A, and D346A, red).
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Fig. S6. RNA sequencing reveals a biological role for DPF2 in HSPCs. RNA sequencing of CB CD34+ cells expressing DPF2 directed or scrambled control shRNAs
was performed 72 h after lentiviral transduction. (A) DPF2 KD efficiency determined by relative DPF2 mRNA expression. (B) Functional annotation of RNA
sequencing analysis by performing GSEA. Representation GSEA plot is shown for datasets with a positive correlation with DPF2 KD. (C) Functional annotation
of RNA sequencing analysis by performing GSEA. Representation GSEA plot is shown for datasets with a negative correlation with DPF2 KD.
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Fig. S7. Schematic representation of the DPF2 interaction network. Endogenous DPF2 was immunoprecipitated from two leukemia cell lines and analyzed by
mass spectrometry. Overlapping DPF2 interaction partners from both cell lines include components of the SWI/SNF complex, COP9 signalosome, spliceosomal
complex, and epigenetic regulators. See also Table S8.
Fig. S8. Analysis of the Cancer Genome Atlas database. (A) Overall AML patient survival rates are plotted for de novo AML cases without alterations in the
DPF2 gene, represented by the blue line, compared with cases with alterations in the DPF2 gene, represented by the red line. (B) Schematic visualizes the 5% of
de novo AML patients that display alterations in DPF2. Patient data and graphs retrieved and adapted from the cBio Portal for cancer genomics (1, 2).
1. Cerami E, et al. (2012) The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404.
2. Gao J, et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1.
Table S1. Bacterial expression constructs
Protein Residues (mutations) Expression vector Restriction sites 5′, 3′ N-terminal overhang
hsDPF2* 270–391 pGEX-6P-1 BamHI, NotI Gly-Met-Gly-Ser
hsDPF2 270–391 (F275A R300A D346A) pGEX-6P-1 BamHI, NotI Gly-Met-Gly-Ser
*Construct that was used for crystallization of hsDPF2270–391.
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Table S2. Crystallographic analysis
Data collection
Protein DPF2PHD DPF2PHD
PDB ID code 5VDC
Synchrotron SSRL SSRL
Beamline BL12-2 BL12-2
Space group I422 I422
Cell dimensions
a, b, c (Å) a = 107.1, b = 107.1, c = 52.9 a = 107.5, b = 107.5, c = 53.3
α, β, γ (°) α = 90.0, β = 90.0, γ = 90.0 α = 90.0, β = 90.0, γ = 90.0
Zn peak
Wavelength (Å) 1.2818 0.9795
Resolution (Å) 50–1.8 50–1.6
Rmeas (%)* 6.1 (95.9) 6.9 (171.5)
Rpim (%)* 1.3 (16.2) 1.3 (38.8)
<I>/<σI>* 33.0 (3.2) 28.9 (2.2)
CC1/2* 100.0 (89.7) 100 (77.8)
Completeness (%)* 100.0 (99.9) 99.0 (98.3)
No. of observations 604,981 540,122
No. of unique reflections* 27,282 (4,408) 20,713 (3,249)
Redundancy* 22.2 (21.9) 26.1 (26.9)
Refinement
Resolution (Å) 50–1.6
No. of reflections 20,405
No. of reflections test set 1,018
Rwork/Rfree (%) 14.6/18.7
No. atoms (nonhydrogen) 1,106
Protein 1,003
Ligand/Ions 16
Water 87
B-factors 38
Protein 37
Ligand/Ions 61
Water 51
Rmsd
Bond lengths (Å) 0.008
Bond angles (°) 1.2
Ramachandran plot†
Favored (%) 97.6
Additionally allowed (%) 2.4
Outliers (%) 0.0
MolProbity score† 1.25
*Highest-resolution shell is shown in parentheses.
†As determined by MolProbity (1).
1. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375–W383.
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Table S3. Isothermal titratrion calorimetry measurements
Protein Peptide Salt concentration (mM) Kd (μM) ΔH (kcal/mol) ΔS (cal/mol/deg)
DPF2WT H3 No salt 0.05 ± 0.02 −6.2 ± 0.4 12.5
50 0.2 ± 0.1 −6.7 ± 0.7 8.2
100 1.0 ± 0.3 −6.2 ± 0.2 6.8
H3K14Ac No salt 0.04 ± 0.02 −10.2 ± 0.5 0.1
50 0.2 ± 0.02 −9.7 ± 0.1 −2.3
100 1.1 ± 0.4 −9.7 ± 0.2 −5.3
H4 No salt 0.2 ± 0.04 −6.7 ± 0.3 8.0
50 3.9 ± 1.5 −7.0 ± 0.1 1.4
100 30.2 ± 13.2 −6.3 ± 0.7 −0.2
H4K16Ac No salt 0.6 ± 0.3 −8.9 ± 6.7 −1.1
50 6.8 ± 1.0 −10.7 ± 0.5 −12.0
100 50.4 ± 5.7 −9.0 ± 0.5 −10.5
RUNX1R223Me No salt Not measurable Not measurable Not measurable
RUNX1R223ADMA No salt Not measurable Not measurable Not measurable
DPF2MUT H3 50 24.8 ± 4.8 −5.1 ± 0.3 4.1
100 Not measurable Not measurable Not measurable
H3K14Ac No salt 2.8 ± 0.1 −6.0 ± 0.2 5.4
50 39.5 ± 13.0 −5.3 ± 0.5 2.4
100 Not measurable Not measurable Not measurable
H4 50 16.4 ± 1.3 −3.1 ± 0.3 11.6
100 Not measurable Not measurable Not measurable
H4K16Ac No salt 3.4 ± 0.2 −4.9 ± 0.3 8.7
50 48.1 ± 9.7 −3.7 ± 0.3 7.4
100 Not measurable Not measurable Not measurable
DPF3b* H3 50 2.3 ± 0.7 −4.4 ± 0.2 11.1
H3K14Ac 50 0.5 ± 0.1 −6.6 ± 0.1 6.7
H4 50 28.8 ± 7.8 −3.3 ± 0.4 9.7
H4K16Ac 50 46.9 ± 10.0 −4.6 ± 0.6 4.4
*Data reported in Zeng et al. (1).
1. Zeng L, et al. (2010) Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 466:258–262.
Table S4. Mammalian expression constructs
Protein Residues (mutations)/target sequence Expression vector Restriction sites 5′, 3′ Source
hsDPF2 1–391 pCDH-EF1-MCS-(PGK-GFP) BamHI Present study
hsDPF2 1–391 (F275A R300A D346A) pCDH-EF1-MCS-(PGK-GFP) BamHI Present study
hsDPF2PHD 270–391 pCDH-EF1-MCS-(PGK-GFP) BamHI Present study
FLAG-hsDPF2 1–391 pCDNA3.1-FLAG EcoRI, NotI Present study
FLAG-hsDPF2 1–391 (F275A R300A D346A) pCDNA3.1-FLAG EcoRI, NotI Present study
hsDPF2 shRNA CCAGGCCTCAGTTACCACTAT pLKO.1-U6-(PGK-GFP) EcoRI, AgeI Present study
Control shRNA GGAATCTCATTCGATGCATAC pLKO.1-U6-(PGK-GFP) EcoRI, AgeI Present study
FLAG-hsRUNX1c 1–480 pBGJR-EF1-(PGK-GFP) RsrII Vu et al. (1)
1. Vu LP, et al. (2013) PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex. Cell Reports 5:1625–1638.
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Table S5. Significant GO-terms enriched in the DPF2 KD dataset
GO term-enriched DPF2 KD vs. Control (438 genes) P value
Regulation of transcription, DNA-templated (GO:0006355) 4.63E-06
Regulation of metabolic process (GO:0019222) 5.51E-06
Regulation of cellular biosynthetic process (GO:0031326) 6.67E-06
Regulation of macromolecular biosynthetic process (GO:0010556) 7.46E-06
Regulation of RNA biosynthetic process (GO:2001141) 7.58E-06
Regulation of nucleic acid-templated transcription (GO:1903506) 8.28E-06
Regulation of gene expression (GO:0010468) 8.39E-06
Regulation of RNA metabolic process (GO:0051252) 1.43E-05
Transcription, DNA-templated (GO:0006351) 1.56E-05
Nucleic acid-templated transcription (GO:0097659) 1.60E-05
M-phase (GO:0000279) 4.20E-02
Results for the significant GO-terms enriched in the DPF2-KD data set compared with
the control and analyzed by the GO and PANTHER classification system.
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Table S6. Enriched genes for “negative regulation of transcription DNA dependent” with positive correlation to
DPF2 KD
Sample Description
GLIS1 GLIS1 family zinc finger 1
ZNF177 Zinc finger protein 177
NR0B1 Nuclear receptor subfamily 0, group B, member 1
NKX2-5 NK2 transcription factor related, locus 5 (Drosophila)
ZBTB32 Zinc finger and BTB domain containing 32
SMAD3 SMAD, mothers against DPP homolog3 (Drosophila)
BMP2 Bone morphogenetic protein 2
SIRT4 Sirtuin (silent mating type information regulation 2 homolog) 4 (Saccharomyces cerevisiae)
TGIF1 TGIFB induced factor homeobox 1
RYBP RING1 and YY1 binding protein
ZBTB16 Zinc finger and BTB domain containing 16
GLI2 GLI-Kruppel family member GLI2
POU4F2 POU domain, class4, transcription factor 2
MDM2 Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)
DRAP1 DR1-associated protein 1 (negative cofactor 2α)
KDM5B Lysine demethylase 5B
ZNF345 Zinc finger protein 345
ZEB1 Zinc finger E-box binding homeobox 1
HDAC5 Histone deacetylase 5
CIR1 Corepressor interacting with RBPJ,1
KLF11 Kruppel-like factor 11
ARID5B AT rich interactive domain 5B (MRF1-like)
NR6A1 Nuclear receptor subfamily 6, group A, member 1
KLF4 Kruppel-like factor 4
TWIST1 Twist homolog 1 (acrocephalosyndactyly 3; Saethre-Chotzen syndrome) (Drosophila)
ARID5A AT rich interactive domain 5A (MRF1-like)
FST Follistatin
MXD4 MAX dimerization protein 4
TBX3 T-box 3 (ulnar mammary syndrome)
SLA2 Src-like-adaptor 2
VHL Von Hippel-Lindau tumor suppressor
JAZF1 JAZF zinc finger 1
RSF1 Remodeling and spacing factor 1
ZNF189 Zinc finger protein 189
PEX14 Peroxisomal biogenesis factor 14
E2F6 E2F transcription factor 6
EID1 EP300 interacting inhibitor of differentiation 1
EPC1 Enhancer of polycomb homolog 1 (Drosophila)
FOXN3 Forkhead box N3
PHF21A PHD finger protein 21A
CBY1 Chibby homolog 1 (Drosophila)
STAT3 Signal transducer and activator of transcription 3 (acute-phase response factor)
SIRT1 Sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)
IRF8 IFN regulatory factor 8
FOSB FBJ murine osteosarcoma viral oncogene homolog B
TP63 Tumor protein P63
ZNF238 Zinc finger protein 238
ZNF136 Zinc finger protein 136
ZHX2 Zinc fingers and homeoboxes 2
SUPT5H Suppressor of TY 5 homolog (S. cerevisiae)
MDM4 Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse)
VPS72 Vacuolar protein sorting 72 (S. cerevisiae)
ZNF281 Zinc finger protein 281
BPTF Bromodomain PHD finger transcription factor
PPARD Peroxisome proliferative activated receptor, δ
IRF7 IFN regulatory factor 7
NRIP1 Nuclear receptor interacting protein 1
ZMYND11 Zinc finger, MYND domain containing 11
ZNF202 Zinc finger protein 202
SPI1 Spleen focus forming virus (SFFV) proviral integration oncogene spi1
HDAC8 Histone deacetylase 8
ARID4A AT rich interactive domain 4A, (RBP1-like)
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Table S6. Cont.
Sample Description
SUPT4H1 Suppressor of Ty 4 homolog 1 (S. cerevisiae)
ZNF174 Zinc finger protein 174
MEIS2 Meis1, myeloid ecotropic viral integration site 1 homolog 2 (mouse)
ZHX1 Zinc fingers and homeoboxes 1
ZNF148 Zinc finger protein 148
SMAD4 SMAD, mothers against DPP homolog 4 (Drosophila)
ZFP161 Zinc finger protein 161 homolog (mouse)
NFX1 Nuclear transcription factor, X-box binding 1
HSBP1 Heat-shock factor binding protein 1
NDUFA13 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
NR0B2 Nuclear receptor subfamily 0, group B, member 2
MECP2 Methyl CpG binding protein 2 (Rett syndrome)
SMARC22 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2
SIRT5 Sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae)
GLIS3 GLIS family zinc finger 3
TBX2 T-box 2
SMAD2 SMAD, mothers against DPP homolog 2 (Drosophila)
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Table S7. Enriched genes for “negative regulation of transcription DNA dependent” with
negative correlation to DPF2 KD
Sample Description
SMARCE1 SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily e, member 1
SIN3A SIN3 homolog A, transcription regulator (yeast)
FOXP3 Forkhead box P3
CTCF CCCTC-binding factor (zinc finger protein)
CUX1 Cut like Homeobox 1
DAXX Death-associated protein 6
MEN1 Multiple endocrine neoplasia I
RB1 Retinoblastoma 1 (including osteosarcoma)
KLF12 Kruppel-like factor 12
LDB1 LIM domain binding 1
NSD1 Nuclear receptor binding SET domain protein 1
E2F1 E2F transcription factor 1
RBPJ Recombination signal binding protein for Ig κ J
CSDA Cold shock domain protein A
MDFI MyoD family inhibitor
TRIM27 Tripartite motif-containing 27
PAWR PRKC, apoptosis, WT1, regulator
ZNF254 Zinc finger protein 254
FOXD3 Forkhead box D3
BCOR BCL6 corepressor
PRDM1 PR domain containing 1, with ZNF domain
ENO1 Enolase 1, (α)
KLF10 Kruppel-like factor 10
ATF7IP Activating transcription factor 7 interacting protein
PHF12 PHD finger protein 12
HEXIM2 Hexamethylene bis-acetamide inducible 2
CHMP1A Chromatin modifying protein 1A
ORC2 Origin recognition complex subunit 2
ZNF396 Zinc finger protein 396
DR1 Down-regulator of transcription 1, TBP-binding (negative cofactor 2)
ZNF593 Zinc finger protein 593
PA2G4 Proliferation-associated 2G4, 38 kDa
GATAD2A GATA zinc finger domain containing 2A
ILF3 Interleukin enhancer binding factor 3, 90 kDa
DNMT1 DNA (cytosine-5-)-methyltransferase
HEXIM1 Hexamethylene bis-acetamide inducible 1
BCL6 B-cell CLL/lymphoma 6 (zinc finger protein 51)
GFI1B Growth factor independent 1B (potential regulator of CDKN1A,
translocated in CML)
IRF2 IFN regulatory factor 2
ZNF157 Zinc finger protein 157
TCEAL1 Transcription elongation factor A (SII)-like 1
HMGB1 High-mobility group box 1
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Table S8. RUNX1 and DPF2 interaction partners
Methyl RUNX1 Interaction partners DPF2 Interaction partners
ACTB MED16 ACAD9 ETFA NSRP1
ARID1A MED17 ACLY FAM102B NSUN4
ARID3A MED26 ACOT13 FAM120A NXN
ASH2L MEN1 ACTL6A FAM133A OLA1
BAF53a MLLT1 ACTR5 FAM32A PAPOLG
BRD9 MTA2 AIMP1 FAM76B PCCB
C2orf44 NDC80 AIMP2 FOXK1 PDIA6
CBFA2T3 NOL5A ARF1 FUBP3 PHAX
CCNK NONO ARF4 GATAD2A PIP
CDC16 NUP85 ARID1B GFPT1 PKMYT1
CDKN2AIP ORC2L ARPC1B GMFB PLOD3
CLTC PABPC1 ASH2L GPATCH8 PLRG1
COBRA1 PABPC4 ATP13A1 GPS1 PNISR
CPSF3 PAXIP1 ATP2A1 H1F0 POLR1C
CPSF6 PRMT5 ATP2A2 HBB POLR1D
CSTF2 PSIP1 ATP5C1 HBG1 POLR2C
CSTF2T PSPC1 ATXN2L HDAC2 POLR2E
CTPS RAD18 BCR HIST1H1D POLR3D
DDX1 RANGAP1 BRD9 HIST1H1E PPIL4
DDX17 RARS BRIX1 HIST1H2AD PPP1CA
DDX21 RBBP5 BRPF3 HMGXB4 PPP2CA
DDX3X RBM14 CALML3 HNRNPAB PRKCB
DDX41 RBM39 CAPN1 HNRNPR PRMT1
DDX5 RPA1 CAPZA1 HSP90AA2 PRPH
DHX15 RPAP2 CARS HSP90B1 PRSS3
DHX36 SF1 CBX8 HSP90B2P PSMA1
DHX9 SF3B2 CCDC59 IMMT PSMC6
DPF2 SF3B3 CCNT1 IMP4 PSPC1
EEF1A1 SFPQ CDC16 INA PTBP3
EEF1A2 SMARCA4 CDK18 KIF26A PTPRE
EWSR1 SMARCC1 CDK9 KLC4 RAB6A
EZR SMARCC2 CEP112 LARP1 RAP1A
FAF1 SMARCD1 CEP170 LASP1 RAP2B
FERMT3 SNRNP70 CHID1 LCP1 RBM14
FIP1L1 SNRPD1 CHMP4B LIN28B RPA1
FUBP1 SNX9 CIRBP LRRC59 RPA2
FUS SR140 CIRH1A LUC7L3 RPL26
GATAD2A SRP68 CLTA MAZ RPLP2
GATAD2B SYNCRIP CMAS MCM3 SCYL2
GMPS TAF15 COPS3 MCM6 SF3B1
HIC2 TCF3 COPS4 MED16 SF3B5
HNRNPH1 TFRC COPS5 METAP2 SMARCA4
HNRNPM TKT COPS6 MRM1 SMARCA5
HNRNPR TRAP1 COPS7A MRPL13 SMARCB1
HNRNPU TRIM25 COPS7B MRPL19 SMARCC1
HSPA1A TUBA1B COPS8 MRPL23 SMARCC2
HSPA2 TUBB2A CPSF7 MRPL27 SMARCD1
HSPA5 UBP1 DBT MRPL38 SMARCD2
HSPA8 USP39 DCAF13 MRPL4 SNRNP70
HSPA9 WDR76 DDX1 MRPL43 TAGLN2
IGF2BP1 XRCC6 DDX5 MRPL45 TALDO1
INTS10 XRN2 DHFR MRPS10 TFRC
INTS9 ZNF326 DHX36 MRPS2 TPI1
KHSRP DMBT1 MRPS22 TUBA1B
KIF2B DNAJA3 MRPS35 VPS26A
LARP7 DNAJB11 MYL1 WDHD1
LCP1 DNMT1 MYL12A WDR36
LMNA DPYSL2 MYL6 WDR74
LMNB1 DYNLL1 NAP1L4 XRN2
LRRC40 EIF3A NBR1 ZNF326
LRWD1 EIF3G NEMF ZNF580
MED1 EIF4A2 NOLC1
MED12 EMG1 NOP14
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Table S9. Overlapping interaction partners of asymmetric dimethyl-R223 RUNX1 peptide and DPF2
Protein Description Molecular function
ASH2L Member of SWI/SNF complex Chromatin remodeling, regulation of transcription
BRD9 Bromodomain containing protein 9 Chromatin remodeling, regulation of transcription
CDC16 Cell division cycle 16 Regulation of mitosis
DDX1 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 Translation initiation, RNA splicing
DDX5 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 Translation initiation, RNA splicing
DHX36 DEAH (Asp-Glu-Ala-His) box polypeptide 36 Nucleic acid binding, transcription regulation
GATAD2A GATA zinc finger domain containing 2A Regulation of transcription
HNRNPR Heterogeneous nuclear ribonucleoprotein R Regulation of RNA splicing
LCP1 Lymphocyte cytosolic protein 1 (L-plastin) Actin filament assembly
MED16 Mediator complex subunit 16 Regulation of transcription
PSPC1 Paraspeckle component 1 Regulation of transcription
RBM14 RNA binding motif protein 14 Regulator of transcription
RPA1 Replication protein A1, 70 kDa DNA recombination and repair
SMARCA4 Member of SWI/SNF complex Chromatin remodeling, regulation of transcription
SMARCC1 Member of SWI/SNF complex Chromatin remodeling, regulation of transcription
SMARCC2 Member of SWI/SNF complex Chromatin remodeling, regulation of transcription
SMARCD1 Member of SWI/SNF complex Chromatin remodeling, regulation of transcription
SNRNP70 Small nuclear ribonucleoprotein 70 kDa (U1) Regulation of RNA splicing
TFRC Transferrin receptor (p90, CD71) Cellular iron ion homeostasis, endocytosis
TUBA1B Tubulin, α1b Microtubule assembly
XRN2 5′-3′ exoribonuclease 2 Transcription regulation
ZNF326 Zinc finger protein 326 Regulation of transcription
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